MNKD Competitors & Alternatives
Compare MannKind Corp with similar stocks in the same industry
Biotechnology
MNKD
Main Stock$3.80
Tradestie Score
50
Market Cap
$1.65B
Revenue Growth
0.4%
Analyst Upside
+109.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$32.17
|
$1.32B | - | 57 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$9.08
|
$1.29B | - | 43 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.62
|
$1.29B | - | 71 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.34
|
$1.29B | - | 58 | Compare |
|
ZYME
Zymeworks Inc.
|
$25.15
|
$1.28B | - | 60 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.14
|
$1.27B | - | 55 | Compare |
|
YDES
YD Bio Limited Ordinary Shares
|
$8.11
|
$1.26B | - | 36 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$8.54
|
$1.18B | - | 35 | Compare |
More MNKD Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry